Form 4 for MED MEDIFAST INC
Accepted 2023-02-09 00:00:00 ET · period of report 2023-02-07 · accession 0001628280-23-003049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-09 | 2023-02-07 | MED | HALLQUIST CONSTANCE J. | Dir | P - Purchase | $114.97 | +9.95 | 7,578 | +0.1% | +$1,144 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-07 | P | A | 9.95 | $114.97 | 7,577.51 | D | — | — | (F1) Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock. |